-
1
-
2
-
3
Determinación del polimorfismo pro12ala en el receptor activado por proliferadores de peroxisomas gamma-2 en pacientes que padecen diabetes mellitus tipo 2
Published 2025-01-01Subjects: “…PPARγ2…”
Get full text
Article -
4
-
5
-
6
α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
Published 2025-01-01Subjects: Get full text
Article -
7
Metabolic Activity in Human Intermuscular Adipose Tissue Directs the Response of Resident PPARγ<sup>+</sup> Macrophages to Fatty Acids
Published 2024-12-01Subjects: “…PPARγ…”
Get full text
Article -
8
Editorial: Endocrine disruptors in molecular and structural endocrinology
Published 2025-02-01Subjects: Get full text
Article -
9
-
10
Slow Metabolism–Driven Amplification of Hepatic PPARγ Agonism Mediates Benzbromarone‐Induced Obesity‐Specific Liver Injury
Published 2025-01-01Subjects: Get full text
Article -
11
PPARγ activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress
Published 2025-01-01Subjects: Get full text
Article -
12
Neoandrographolide inhibits mature osteoclast differentiation to alleviate bone loss and treat osteoporosis
Published 2025-02-01Subjects: Get full text
Article -
13
White adipose tissues and skeletal muscles as a target of chrysin during the treatment of obesity in rats
Published 2025-01-01Subjects: Get full text
Article -
14
Effects of benzotriazoles UV-328, UV-329, and UV-P on the self-renewal and adipo-osteogenic differentiation of human mesenchymal stem cells
Published 2025-01-01Subjects: Get full text
Article -
15
Network pharmacology and experimental verification to investigate the mechanism of isoliquiritigenin for the treatment of Alzheimer’s disease
Published 2025-02-01Subjects: Get full text
Article -
16
Targeting TCMR-associated cytokine genes for drug screening identifies PPARγ agonists as novel immunomodulatory agents in transplantation
Published 2025-01-01Subjects: Get full text
Article -
17